+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

UAE Heart Failure Treatment Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5328160
  • Report
  • September 2020
  • Region: United Arab Emirates
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Amgen, Inc.
  • AstraZeneca Plc.
  • Bristol-Myers Squibb
  • Drug Class Portfolio
  • GlaxoSmithKline Plc.
  • Merck & Co., Inc.
Heart failure is characterized by the inability of the heart to pump adequate amount of blood to the body. There are three types of heart failures; left-sided heart failure, right-sided heart failure, and biventricular heart failure. The condition is treated with particular cardiovascular drugs available in the market. Moreover, the treatment for heart failure depends on the stages (stage A, B, C, & D). Drugs such as diuretics, ACE inhibitors, angiotensin 2 receptor blockers, beta blockers, and digitalis are majorly used in the treatment of heart failure.

Various global players are engaged in development of novel therapies and drugs for treating heart failure. In May 2020, AstraZeneca Pharmaceuticals PLC. Received the U.S. Food and Drug Administration’s approval for Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection fraction to reduce risk of cardiovascular death and hospitalization for heart failure.

Key features of the study:
  • This report provides in-depth analysis of the UAE heart failure treatment drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the UAE heart failure treatment drugs market based on the following parameters – company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Novartis International AG, AstraZeneca Plc., Amgen, Inc., Pfizer, Inc., Mylan N.V., Merck & Co., Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The UAE heart failure treatment drugs market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the UAE heart failure treatment drugs market.
Detailed Segmentation

UAE Heart Failure Treatment Drugs Market, By Drug Class:
  • ACE Inhibitors
  • Angiotensin 2 Receptor Blockers
  • Beta Blockers
  • Diuretics
  • Aldosterone Antagonists
  • Inotropes
  • Others
UAE Heart Failure Treatment Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • Novartis International AG*
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • AstraZeneca Plc.
  • Amgen, Inc.
  • Pfizer, Inc.
  • Mylan N.V.
  • Merck & Co., Inc.
  • Bristol-Myers Squibb
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen, Inc.
  • AstraZeneca Plc.
  • Bristol-Myers Squibb
  • Drug Class Portfolio
  • GlaxoSmithKline Plc.
  • Merck & Co., Inc.
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Class
  • Market Snippet, By Distribution Channel
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Impact Analysis
  • Market Opportunities
  • Collaborations and Acquisition
  • Regulatory Scenario
  • Pipeline Analysis
  • Brand Mapping and Pricing Analysis
  • PEST Analysis
  • Reimbursement Scenario
4. UAE Heart Failure Treatment Drugs Market, Impact of COVID-19 Pandemic
  • Overall Impact on Healthcare Market
5. UAE Heart Failure Treatment Drugs Market, By Drug Class, 2016-2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • ACE Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Angiotensin 2 Receptor Blockers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Beta Blockers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Diuretics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Aldosterone Antagonists
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Inotropes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
6. UAE Heart Failure Treatment Drugs Market, By Distribution Channel, 2020 - 2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017- 2027
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
7. Competitive Landscape
  • Company Profiles
  • Novartis International AG
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • AstraZeneca Plc.
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Amgen, Inc.
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Pfizer, Inc.
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Mylan N.V.
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Merck & Co., Inc.
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Bristol-Myers Squibb
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • GlaxoSmithKline Plc.
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Drug Class Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
Note: Product cover images may vary from those shown
  • Novartis International AG
  • Drug Class Portfolio
  • AstraZeneca Plc.
  • Amgen, Inc.
  • Pfizer, Inc.
  • Mylan N.V.
  • Merck & Co., Inc.
  • Bristol-Myers Squibb
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll